COM:MEIPHARMA
MEI Pharma
- Stock
locale
United Statesmarket
STOCKSindustry
Pharmaceuticalswebsite
meipharma.comipo date
Dec 18, 2003
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib mult...Show More